Amplio Spine Advances Non-Cervical Fusion with KeyLift® Acquisition and Launch

Amplio Spine's Innovative Acquisition of KeyLift®

Amplio Spine, a leading name in the medical device sector, has made headlines with its latest acquisition of the KeyLift® Expandable Interlaminar Stabilization System, a product that is not only FDA-cleared but also promises to redefine non-cervical spinal treatments.

A Game-Changer in Spine Surgery

On June 18, 2026, Amplio completed the acquisition from FloSpine, marking a significant step towards national commercialization of this advanced spinal fixation device. The KeyLift system is regarded as a minimal invasive surgical solution, designed for supplemental fusion in a variety of spinal conditions, including lumbar spinal stenosis and degenerative disc disease.

The KeyLift® operates under the FDA classification 21 CFR 888.3050 and stands out due to its innovative usage of plate fixation on the spinous processes and lamina. This distinguished method allows for a more secure attachment, enhancing the overall efficacy of spinal procedures.

Clinical Implications of KeyLift®

The FDA has approved the KeyLift device specifically for use in the non-cervical spine ranging from T1 to S1. It is crucial in surgical practices to treat various ailments such as spondylolisthesis and trauma-related spinal injuries. The device must be used alongside autograft or allograft bone, as it is not intended for standalone application.

Dr. Stephen H. Hochschuler, a notable figure in spine treatment, emphasized the importance of this advancement by stating, “KeyLift technology is among the most secure minimally invasive spinal fusion developments.” This endorsement highlights the potential of the KeyLift system to become a go-to choice among spinal surgeons and interventionalists, propelling it into the forefront of surgical techniques.

The Engineering Brilliance Behind KeyLift®

The concept for the KeyLift device emerged from rigorous engineering and clinical research led by the late Peter Harris. It focuses on achieving supplemental fusion through a posterior, non-pedicle approach, which, as studies suggest, may offer superior strength in spinal fixation compared to traditional techniques.

Two Configurations for Versatile Application

KeyLift is available in two distinct configurations to cater to varying anatomical needs: KeyLiftXL, which is tailored for lumbar anatomy, and KeyLiftXS, designed for the limited space of the lumbosacral region. Each variant offers multiple sizes, allowing for precise fitting to accommodate different structures in the lumbar spine.

Amplio Spine's Vision and Future

Amplio Spine is led by Joshua Lambert, a seasoned healthcare executive who aims to place innovative medical devices in the hands of skilled surgeons. “Our distributor network is fully operational, and we’re ready to make a significant impact in the market,” Lamert stated. The company is positioned to train medical professionals on the use of KeyLift and ensure that they can leverage its capabilities effectively.

With a committed team and a strong product portfolio, Amplio Spine continues to evolve in the medical field, targeting procedures that affect millions globally. The acquisition of the KeyLift system not only signifies a corporate milestone for Amplio Spine but also heralds the potential for improved patient outcomes in spinal care.